*  Exposure Controls/Personal Protection  *
Respiratory Protection:NONE NORMALLY REQUIRED. USE NIOSH/MSHA APPROVED
    RESPIRATOR WITH HEPA FILTER WHEN HANDLING LARGE QUANTITIES OF
    BROKEN OR CRUSHED TABLETS IN THE ABSENCE OF ADEQUATE VENTILATION.
Ventilation:USE ADEQUATE LOCAL EXHAUST WHEN HANDLING LARGE QUANTITIES
    OF BROKEN OR CRUSHED TABLETS.
Other Protective Equipment:WEAR OVERALLS WHEN THE POTENTIAL FOR SEVERE
    DUSTY CONDITIONS EXISTS.
Work Hygienic Practices:WASH HANDS AFTER HANDLING & BEFORE
    EATING,DRINKING,SMOKING,OR USING LAVATORY.LAUNDER CONTAMINATED
    CLOTHES BEFORE REUSE.
Supplemental Safety and Health
PRE-PLACEMENT PHYSICAL EXAMINATION & HISTORY FOR ALL EMPLOYEES WITH
    POTENTIAL FOR EXPOSURE TO MEGACE IS RECOMMENDED. A COMPLETE BLOOD
    COUNT, INCLUDING DIFFERENTIAL, MAY BE TAKEN FOR BASELINE. PERIODIC 
    FOLLOW-UP SHOULD BE GIVEN IAW INSTITUTIONAL POLICY.
*  Product Identification  *
*  Composition/Information on Ingredients  *
Ingred Name:MEGESTROL ACETATE
Other REC Limits:NONE RECOMMENDED
*  Hazards Identification  *
Routes of Entry: Inhalation:NOSkin:NO  Ingestion:NO
Reports of Carcinogenicity:NTP:NO    IARC:NOOSHA:NO
Health Hazards Acute and Chronic:ACUTE: INHALATION OF DUST MAY IRRITATE
    RESPIRATORY TRACT. CONTACT WITH EYES MAY CAUSE CONJUNCTIVITIS. LOW
    ORAL TOXICITY. CHRONIC: SIDE EFFECTS REPORTED INCLUDE EDEMA, DEEP
    VEIN THROMOPHLEBITIS, CARPAL  TUNNEL SYNDROM, ALOPACIA, NAUSEA,
    VOMITING, AND VAGINAL BLEEDING.
Explanation of Carcinogenicity:MANUFACTURER SAYS MEGESTRAL ACETATE IS A
    POSSIBLE CARCINOGEN, BASED ON CONFLICTING ANIMAL DATA.
Effects of Overexposure:INHALED: SNEEZING, COUGH, DIFFICULTY IN
    BREATHING, OR FEELING OF CHEST TIGHTNESS. EYES: REDNESS,
    DISCOMFORT. SKIN: NONE GIVEN. INGESTED: NONE GIVEN.
Medical Cond Aggravated by Exposure:THERAPEUTIC DOSES OF THIS MATERIAL
    MAY AGGRAVATE THROMBOPHLEBITIS.
*  First Aid Measures  *
First Aid:INHALED: REMOVE TO FRESH AIR. IF NOT BREATHING, GIVE
    ARTIFICIAL RESPIRATION. IF BREATHING DIFFICULT, GIVE OXYGEN. EYES:
    DOCTOR. SKIN: WASHWITH SOAP AND WATER. IF IRRITATION DEVELOPS,
    SEE DOCTOR. INGESTED: GET IMMEDIATE MEDICAL ATTENTION. IF CONSCIOUS
    AND NOT CONVULSING, INDUCE VOMITING.
*  Fire Fighting Measures  *
Extinguishing Media:CARBON DIOXIDE, FOAM, OR DRY CHEMICAL
Fire Fighting Procedures:WEAR SELF-CONTAINED BREATHING APPARATUS AND
    FULL PROTECTIVE GEAR. EVACUATE NON-ESSENTIALS UPWIND, REMOVE
    UNEEDED MATERIALS, AND COOL CONTAINERS WITH WATER.
Unusual Fire/Explosion Hazard:CONTAINS POTENT STEROID. DECONTAMINATE
    PROTECTIVE EQUIPMENT AFTER USE. AVOID INGESTION, INHALATION, OR
    SKIN CONTACT.
*  Accidental Release Measures  *
Spill Release Procedures:SCOOP UP TABLETS AND PLACE IN A CONTAINER FOR
    LATER DISPOSAL. CLEAN RESIDUAL POWDER WITH DAMP RAG OR TOWELS. WASH
    AREA THOROUGHLY WITH WATER AND DETERGENT. TREAT PRODUCTS AND
    CONTAMINATED MATERIALS AS  IF THEY WERE HAZARDOUS MATERIALS.
Neutralizing Agent:NONE SPECIFIED BY MANUFACTURER.
*Handling and Storage  *
Handling and Storage Precautions:STORE IN A COOL, DRY PLACE AT ROOM
    TEMPERATURE; AVOID EXCESSIVE HEAT.
Other Precautions:AVOID INHALATION, SKIN OR EYE CONTACT WITH CRUSHED OR
    BROKEN TABLETS.
*  Physical/Chemical Properties  *
HCC:K2
Solubility in Water:NEGLIGIBLE
Appearance and Odor:LIGHT BLUE, ROUND, FLAT-FACED BEVELED-EDGE BISECTED
    TABLETS
*  Stability and Reactivity Data  *
Stability Indicator/Materials to Avoid:YES
Hazardous Decomposition Products:OXIDES OF CARBON
*  Disposal Considerations  *
Waste Disposal Methods:MANUFACTURER RECOMMENDS INCINERATION AT
    PERMITTED SITE. DISPOSE OF IN ACCORDANCE WITH LOCAL, STATE AND
    FEDERAL REGULATIONS.
